CompletedPhase 4NCT00818818

Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age Patients

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Brasilia
Principal Investigator
Julia S Ampuero-Vela, MD, MSc
Faculty of Medicine, University of Brasilia
Intervention
Meglumine antimoniate(drug)
Enrollment
13 target
Eligibility
65 years · All sexes
Timeline
20082010

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00818818 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis

← Back to all trials